Micromanaging microRNAs: Using murine models to study microRNAs in lung fibrosis

18Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

MicroRNAs are implicated in many biological and pathological processes and are emerging as key actors in lung health and disease. Specific patterns of dysregulated microRNAs have been found in idiopathic pulmonary fibrosis (IPF), an untreatable interstitial lung disease of unknown etiology. IPF is characterized by dramatic and extensive phenotypic changes in the lung that include alveolar cell hyperplasia, fibroblast proliferation and formation of myofibroblast foci, deposition of extracellular matrix, and changes in lung transcriptional programming. Here, we discuss the latest insights about the role of microRNAs in lung fibrosis with a focus on the contribution of animal models of disease to the derivation of these insights. © 2012 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Lino Cardenas, C. L., Kaminski, N., & Kass, D. J. (2013). Micromanaging microRNAs: Using murine models to study microRNAs in lung fibrosis. Drug Discovery Today: Disease Models. Elsevier Ltd. https://doi.org/10.1016/j.ddmod.2012.11.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free